1. Home
  2. THM vs REPL Comparison

THM vs REPL Comparison

Compare THM & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$2.30

Market Cap

723.2M

Sector

N/A

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.65

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THM
REPL
Founded
1978
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.2M
692.8M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
THM
REPL
Price
$2.30
$7.65
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$11.13
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
03-11-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5.25
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$2.68
52 Week High
$3.65
$13.24

Technical Indicators

Market Signals
Indicator
THM
REPL
Relative Strength Index (RSI) 44.86 52.32
Support Level $2.17 $6.71
Resistance Level $3.63 $8.07
Average True Range (ATR) 0.19 0.49
MACD -0.03 0.04
Stochastic Oscillator 36.25 80.07

Price Performance

Historical Comparison
THM
REPL

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: